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ABSTRACT
Firstly described by Rudolf Virchow in the 19th century, congenital generalized lymphangiectasia is a rare entity characterized 
by dilation of lymphatic vessels, and was recently classified in primary or secondary lymphangiectasia. Generalized forms 
may be diagnosed during pre-natal follow-up with ultrasound examination, and, depending on its severity, the newborn 
outcome is very poor. The authors report the case of a female newborn with a previous diagnosis of fetal hydropsy who 
was born after a full-term gestation with respiratory failure due to bilateral voluminous pleural effusion and ascites. 
Physical examination also disclosed syndromic facies. Despite all efforts of the intensive supportive care, the patient died 
after 24 days of life. The autopsy findings were consistent with the diagnosis of congenital pulmonary lymphangiectasia. 
The authors call attention to this rare diagnosis in patients with cavitary effusion and respiratory insufficiency at birth. 
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CASE REPORT
A full-term female (39 and 4/7 weeks) was 
born through a cesarean section with hypotonia 
and cyanosis, a faint cry, bradycardia, and irregular 
respiratory pattern. The Apgar score was 3/5/8 and 
the weight was 3220 g. Plain chest x-ray is shown in 
Figure 1.
Still in the delivery room, orotracheal intubation, 
bilateral thoracocentesis, and paracentesis due to 
anasarca and respiratory failure were performed to 
achieve some improvement in the newborn vitality.
This was the second pregnancy of the mother 
who was 30 years old and who had attended four 
prenatal consultations. Her blood type was A, 
Rh-positive. The tests for irregular anti-erythrocytes 
antibodies were negative as well as the serology for 
HIV, syphilis, and parvovirus. She was immune for 
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rubella and cytomegalovirus, but was susceptible 
for toxoplasmosis. She denied any comorbidity, 
consanguinity, and illicit drug abuse. She was referred 
to the hospital for fetal vitality assessment since the 
pregnancy was at the 40th week. The ultrasound 
disclosed hydramnios (amniotic fluid index of 31.4 cm 
[reference value (RV): 5-25 cm]) and signs consistent 
with fetal hydropsy (pleural effusion and ascites), 
which were not previously detected. Therefore, the 
cesarean section was performed. A detailed physical 
examination of the newborn evidenced flattened nose, 
low-set ears, a short neck and a nuchal fold, which 
raised the suspicion of Noonan syndrome. The outcome 
was characterized by relapsing non-chylous pleural 
effusion, mainly in the right hemithorax requiring 
right thoracic drainage. The abdominal ultrasound 
showed a moderate amount of ascites with thin 
septa. The echocardiogram did not reveal cardiac 
malformations and the karyotype was 46XX.
On the 12th day of the neonatal intensive 
care unit hospitalization, the patient started with 
fever and worsening of the clinical and laboratory 
parameters consistent with late neonatal septicemia 
and shock accompanied by multiple organ failure. 
Serratia marcescens was isolated in the blood cultures. 
The child died on the 24th day after birth.
AUTOPSY FINDINGS
The ectoscopy showed a female newborn 
weighing 4.585 g (RV: 2789 ± 520 g) and measuring 
51.5 cm in length (RV: 46.7 ± 4.4 cm). The face 
showed a flattened nose, low-set ears and a short neck. 
The corpse was in anasarca with marked palpebral and 
genital edema, and a distended abdomen.
At the opening of the cavities, hemorrhagic ascites 
and citrine pleural effusion were drained.
The cervical region did not present cystic hygroma 
or cystic dilation of lymphatic vessels. The thyroid 
parenchyma presented dilated lymphatic vessels 
between the follicles.
In the abdominal cavity, the serosa presented 
a smooth surface without lymphangiectas ia 
macroscopically identified, but at microscopy dilated 
lymphatic vessels were found in the surface of the small 
intestine, in the adjacent fibroadipose tissue of adrenal 
glands, kidneys, retroperitoneum, and peripancreatic 
adipose tissue (Figure 2).
The pleural surfaces were smooth without cystic 
lesions The pulmonary parenchyma’s cut surface was 
homogeneous, firm, and purplish colored. The right 
lung weighed 48.5 g and the left lung weighed 
40.5 g (RV: 42.6 ± 14.9 g). The microscopy showed 
the saccular stage of pulmonary development 
with areas of atelectasis and several congested 
capillaries in the alveolar septa. The peribronchial 
arteries presented marked myointimal hyperplasia 
with organizing thrombi and plexiform alterations 
consistent with severe pulmonary hypertension. Dilated 
interlobular and visceral pleural lymphatic vessels were 
identified with thin intraluminal septa, which, on the 
immunohistochemical research, showed positivity for 
CD31, CD34, and D2-40 (Figures 3 and 4).
The heart weighed 22.1 g (RV: 19.1 ± 2.8 g) and 
presented patent oval foramen and patency of the 
arterial duct; however, no malformations were found.
The brain weighed 373.6 g (RV: 337 ± 91 g) and 
had a softened consistency with congested meninges, 
which, at microscopy, were thickened due to acute 
inflammatory infiltrate. Neither Grocott’s nor Brown-
Hopps staining identified no microorganisms.
Other findings consistent with shock were areas 
of splenic ischemic infarction, and renal acute tubular 
necrosis. The liver presented lobular infarction in 
Figure 1. Plain chest x-ray showing bilateral 
homogeneous opacification due to voluminous pleural 
effusion.
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zones 2 and 3 with microvesicular steatosis besides 
extramedullary hematopoiesis (Figure 5).
DISCUSSION
Congenita l  pulmonary lymphangiectas i s 
(CPL) is a rare vascular disorder characterized by 
distended or dilated pulmonary lymphatic vessels 
in the bronchovascular connective tissue along the 
interlobular septa and in the pleura.1
In 1856, Rudolf Virchow2 was the first to describe 
CPL, followed by 38 new descriptions until 1968. 
In 1970, Noonan et al.3 reported three new cases 
among another 45 known cases, and classified 
them into three groups: (i) 5 cases of a generalized 
form of lymphangiectasis with primarily intestinal 
involvement and less severe pulmonary disease; 
(ii) 13 cases of secondary pulmonary lymphagiectasis 
(PL) due to pulmonary venous hypertension or 
obstruction (often associated with congenital heart 
disease); and (iii) 30 cases with primary PL, associated 
with an aggressive course and poor prognosis.4 
This classification has been modified and divided 
into two major categories defined as primary and 
secondary CPL. Primary CPL fits into the category 
of systemic lymphatic features that include hydrops 
fetalis, chylous ascites, intestinal lymphangiectasis, 
pleural and pericardial effusions, and PL. Secondary 
CPL includes a heterogeneous group of conditions, 
such as hypoplastic left heart syndrome, pulmonary 
vein atresia, congenital mitral stenosis, cor triatriatum, 
and thoracic duct agenesis.4,5
Figure 2. Photomicrography of the lymphangiectasia. A - Small bowel serosa (H&E, 100X). B - Fibroadipose 
tissue surrounding the adrenal gland (H&E, 100X). C - Peripancreatic tissue (H&E, 100X). D - Thyroid parenchyma 
(H&E, 100X).
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The incidence of CPL is not clearly defined 
because there were only a few isolated cases or 
a small series of reported cases. Autopsy studies 
suggest that 0.5-1% of infants who are stillborn or 
die in the neonatal period have CPL.6 A recent report 
on the histopathological spectrum of congenital 
pulmonary development disorder stated that out of 
2155 stillbirth/neonatal autopsies there were two cases 
of CPL. These data would suggest that approximately 
1/1000 stillbirth/neonatal deaths are—to some 
degree—attributable to CPL.4,7
The etiology of CPL is not known. Blood vessels 
originate from a mesoderm-derived endothelial cell 
precursor, and the lymphatic vasculature appears 
whichever the 9th week of gestation. Between the 12th 
and 16th weeks of fetal life, the pulmonary lymphatic 
tissue is well developed. Later, in the 20th week of fetal 
life, the lymphatic channels become narrower and the 
surrounding connective tissue diminishes.4 Laurence8 
postulated a theory that lymphangiectasis is due to a 
developmental error in which the normal regression of 
connective tissue elements fails to occur. The presence 
of a lymphatic septum is not a characteristic of CPL, 
but we observed a focal lymphatic septum, similar to 
an intraluminal valve, in an ectatic lymphatic vessel 
in the pulmonary parenchyma. It could be a sign of 
lymphatic dysplasia. During development, after the 
establishment of a primary lymphatic vasculature, 
lymphatic vessels undergo further remodeling to form 
a hierarchical vascular tree composed of lymphatic 
capillaries, pre-collectors, and collecting vessels. 
Lymphatic capillaries are blind-ended thin-walled 
Figure 3. A - Gross findings of the lungs with smooth surface and purplish areas. B - Saccular stage of pulmonary 
development with several congested vessels in the thickened septa (H&E, 100X). C - Peribronchial arteries with marked 
myointimal thickening and organizing thrombosis (H&E, 100X). D - Myointimal hyperplasia in the peribronchial 
arteries (Masson, 100X).
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vessels, which lack mural cell coverage, and are devoid 
of a continuous basement membrane. The pre-collector 
vessels display similar properties as capillaries with the 
exception that they also contain bi-leaflet intraluminal 
valves like those seen in the large collecting vessels.9
The clinical presentation of CPL in the antenatal 
period can be similar to non-immune hydrops 
fetalis with hydrothorax, often in combination 
with polyhydramnios. Severe respiratory distress, 
due to unilateral or bilateral pleural effusions, 
pulmonary hypoplasia, and surfactant deficiency in 
combination with prematurity leading to intubation 
and mechanical ventilation, is the usual presentation 
at birth. Patients with generalized CPL usually have 
less pulmonary involvement but develop more 
subcutaneous edema and visceral effusions.4,10 
The main neonatal complications are persistent 
Figure 4. Photomicrography of the lung. A - Dilated lymphatic vessels in the visceral pleura (H&E, 100X). B - Dilated 
lymphatic vessels within alveolar septa (H&E, 100X). C - Detail of the lymphatic vessel with intraluminal septum 
(H&E, 200X). D - Immunohistochemichal positive reaction for D2-40 in the lymphatic vessels (100X).
visceral chylous effusions, mechanical ventilatory 
support addiction, anasarca, arterial hypotension, 
heart failure, secondary pulmonary hypertension, 
nosocomial infections, and neonatal death, usually 
as a consequence of progressive respiratory failure.11
We report the case of a neonate with persistent 
visceral effusion and anasarca, with autopsy findings 
showing generalized lymphangiectasis and a less 
evident pulmonary evolvement, which altogether could 
represent a generalized form of CPL. The presence 
of immature pulmonary parenchyma and signals of 
secondary pulmonary hypertension were noted in this 
case, which are also described by other autopsy case 
reports in the literature.1,9 Although group 1 CPL is 
usually associated with mild pulmonary involvement 
and symptoms with a better prognosis, our case had 
severe pulmonary symptoms, which we attribute to 
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the premature and insufficiently expanded pulmonary 
parenchyma, with secondary pulmonary hypertension, 
causing the severe pulmonary symptoms. The acute 
meningitis and septic shock also contributed to the 
fatal outcome. Even though associated congenital or 
chromosomal anomalies could not be ruled out by 
molecular analysis, Noonan syndrome was considered 
in the differential diagnosis. It is usually associated 
with congenital heart disease, but that was absent in 
our case.
Nevertheless, most cases of CPL occur sporadically 
in association with chromosomal anomalies as 
Turner ,  Down,  Phe lan–McDermid ,  Noonan, 
Cardio-Facio-Cutaneous, Costello, and Hennekam.4 
In the presence of intestinal lymphangiectasis, 
Hennekam syndrome (HS) also should be considered 
among the differential diagnoses. HS has congenital 
intest inal  lymphangiectas ia,  without marked 
respiratory features at birth, with protein-losing 
gastroenteropathy resulting in peripheral edema, 
ascites, hypogammaglobulinemia, lymphopenia, and 
electrolytes imbalance. In this syndrome, facial features 
are characterized by a flat face, a flat and broad nasal 
bridge, and hypertelorism, which reflect the extent 
of the intrauterine facial lymphedema.1 To date, the 
CCBE1 mutation is the single detectable genetic 
alteration for HS.4
The diagnosis of CPL is often based on clinical 
signs, imaging, and histological findings. The gold 
standard for diagnosis is open-lung biopsy. Histological 
examination is helpful in the differential diagnosis 
of diffuse pulmonary lymphangiomatosis, interstitial 
Figure 5. A - Photomicrography of the meninx with acute inflammatory infiltrate (H&E, 200X). B - Photomicrography 
of the kidney with acute tubular necrosis (H&E, 100X). C - Photomicrography of the spleen with ischemic infarction 
(H&E,100X). D - Photomicrography of the liver with lobular infarction, sinusoidal congestion, and extramedullar 
hematopoiesis (H&E, 100X).
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pneumonia, interstitial emphysema, and congenital 
cystic adenomatoid malformation.4,10 Systemic 
lymphangiectasis becomes evident only when 
post-mortem examinations are performed, contributing 
to the differential diagnosis between CPL groups 1 and 
3.4 Although imaging findings are not specific, thoracic 
computed tomography or plain chest radiography 
are usually described as presenting reticulonodular 
infiltrate with increased interstitial thickening, due to 
dilated pulmonary lymphatics. An alternate imaging 
exam is lymphoscintigraphy, which identifies lymph 
vessel abnormalities, but is rarely reported.4,12
The postnatal therapeutics options are primarily 
support ive care with aggress ive mechanica l 
ventilation, surfactant administration, thoracocentesis, 
cardio-circulatory support, total parenteral nutrition, 
and substitution of losses of electrolytes, coagulation 
factors ,  and immunoglobul in.  Octreot ide,  a 
somatostatin analog, is a therapeutic option for 
persistent chylothorax, with a direct effect on the 
splanchnic circulation resulting in vasoconstriction, 
and decreasing chyle production. Pleurodesis or 
surgical interventions, such as pleurectomy or thoracic 
duct ligation, are possible for cases that evolve with 
relapsing pleural effusion.4
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